. However, despite the availability of disopyramide for over 35 years, the mechanism by which this drug provides the observed clinical benefit has not been well characterized in this complex heart disease, contributing to some apprehension and concern within the practicing cardiology community in recommending disopyramide therapy to patients with HCM (4, 5) . Science author instructions page. 
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